nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—MPO—Dapsone—leprosy	0.379	0.411	CbGbCtD
Tolmetin—PTGS2—Thalidomide—leprosy	0.164	0.177	CbGbCtD
Tolmetin—PTGS1—Thalidomide—leprosy	0.138	0.15	CbGbCtD
Tolmetin—PTGS2—Dapsone—leprosy	0.131	0.142	CbGbCtD
Tolmetin—PTGS1—Dapsone—leprosy	0.11	0.12	CbGbCtD
Tolmetin—MPO—IL23-mediated signaling events—IL23R—leprosy	0.00552	0.151	CbGpPWpGaD
Tolmetin—Proteinuria—Dapsone—leprosy	0.00258	0.079	CcSEcCtD
Tolmetin—Protein urine present—Dapsone—leprosy	0.00255	0.0779	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TNFSF15—leprosy	0.00235	0.0643	CbGpPWpGaD
Tolmetin—Proteinuria—Thalidomide—leprosy	0.00132	0.0404	CcSEcCtD
Tolmetin—Protein urine present—Thalidomide—leprosy	0.0013	0.0399	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TLR1—leprosy	0.00126	0.0346	CbGpPWpGaD
Tolmetin—TDO2—Monoamine Transport—TNF—leprosy	0.00122	0.0333	CbGpPWpGaD
Tolmetin—MPO—blood vessel—leprosy	0.00111	0.126	CbGeAlD
Tolmetin—Blood urea increased—Thalidomide—leprosy	0.0011	0.0335	CcSEcCtD
Tolmetin—Tinnitus—Dapsone—leprosy	0.00106	0.0325	CcSEcCtD
Tolmetin—PTGS2—hindlimb—leprosy	0.00105	0.119	CbGeAlD
Tolmetin—Lymphadenopathy—Thalidomide—leprosy	0.000989	0.0302	CcSEcCtD
Tolmetin—TDO2—nervous system—leprosy	0.000985	0.112	CbGeAlD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	0.000985	0.027	CbGpPWpGaD
Tolmetin—Vascular purpura—Thalidomide—leprosy	0.000943	0.0288	CcSEcCtD
Tolmetin—Cardiac failure congestive—Thalidomide—leprosy	0.00093	0.0284	CcSEcCtD
Tolmetin—PTGS2—appendage—leprosy	0.000902	0.102	CbGeAlD
Tolmetin—Visual disturbance—Thalidomide—leprosy	0.00089	0.0272	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—IFNG—leprosy	0.000879	0.0241	CbGpPWpGaD
Tolmetin—Purpura—Thalidomide—leprosy	0.000875	0.0268	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—leprosy	0.000871	0.0239	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—CD4—leprosy	0.000849	0.0233	CbGpPWpGaD
Tolmetin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000843	0.0258	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—IL2—leprosy	0.000781	0.0214	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	0.000778	0.0213	CbGpPWpGaD
Tolmetin—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00076	0.0232	CcSEcCtD
Tolmetin—PTGS2—skin epidermis—leprosy	0.00075	0.0851	CbGeAlD
Tolmetin—CXCL8—Overview of nanoparticle effects—TNF—leprosy	0.000719	0.0197	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—IFNG—leprosy	0.00068	0.0186	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL10—leprosy	0.000666	0.0182	CbGpPWpGaD
Tolmetin—Weight increased—Thalidomide—leprosy	0.000663	0.0203	CcSEcCtD
Tolmetin—Gastrointestinal pain—Dapsone—leprosy	0.000662	0.0202	CcSEcCtD
Tolmetin—Weight decreased—Thalidomide—leprosy	0.00066	0.0202	CcSEcCtD
Tolmetin—Drowsiness—Thalidomide—leprosy	0.00065	0.0199	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TLR2—leprosy	0.000643	0.0176	CbGpPWpGaD
Tolmetin—Body temperature increased—Dapsone—leprosy	0.00064	0.0196	CcSEcCtD
Tolmetin—Abdominal pain—Dapsone—leprosy	0.00064	0.0196	CcSEcCtD
Tolmetin—Renal failure—Thalidomide—leprosy	0.000639	0.0195	CcSEcCtD
Tolmetin—Stomatitis—Thalidomide—leprosy	0.000634	0.0194	CcSEcCtD
Tolmetin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.000626	0.0171	CbGpPWpGaD
Tolmetin—Haematuria—Thalidomide—leprosy	0.00062	0.0189	CcSEcCtD
Tolmetin—CXCL8—EBV LMP1 signaling—TNF—leprosy	0.000617	0.0169	CbGpPWpGaD
Tolmetin—Epistaxis—Thalidomide—leprosy	0.000613	0.0187	CcSEcCtD
Tolmetin—Agranulocytosis—Thalidomide—leprosy	0.000607	0.0185	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—IL10—leprosy	0.000604	0.0166	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—CD40LG—leprosy	0.000604	0.0166	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—leprosy	0.00059	0.0162	CbGpPWpGaD
Tolmetin—Hepatitis—Thalidomide—leprosy	0.000584	0.0178	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—TNF—leprosy	0.000569	0.0156	CbGpPWpGaD
Tolmetin—Visual impairment—Thalidomide—leprosy	0.000562	0.0172	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—IFNG—leprosy	0.000553	0.0152	CbGpPWpGaD
Tolmetin—CXCL8—testis—leprosy	0.000553	0.0627	CbGeAlD
Tolmetin—Erythema multiforme—Thalidomide—leprosy	0.000552	0.0169	CcSEcCtD
Tolmetin—Tinnitus—Thalidomide—leprosy	0.000544	0.0166	CcSEcCtD
Tolmetin—PTGS1—blood vessel—leprosy	0.000525	0.0596	CbGeAlD
Tolmetin—Vomiting—Dapsone—leprosy	0.000515	0.0157	CcSEcCtD
Tolmetin—MPO—skin of body—leprosy	0.000513	0.0582	CbGeAlD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—leprosy	0.000512	0.014	CbGpPWpGaD
Tolmetin—Headache—Dapsone—leprosy	0.000507	0.0155	CcSEcCtD
Tolmetin—PTGS2—blood vessel—leprosy	0.000502	0.057	CbGeAlD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	0.000502	0.0137	CbGpPWpGaD
Tolmetin—Flatulence—Thalidomide—leprosy	0.000501	0.0153	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—IL2—leprosy	0.000492	0.0135	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—HLA-DRB1—leprosy	0.000487	0.0133	CbGpPWpGaD
Tolmetin—Nausea—Dapsone—leprosy	0.000481	0.0147	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—leprosy	0.000455	0.0125	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—IFNG—leprosy	0.000449	0.0123	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CD4—leprosy	0.000441	0.0121	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—TNF—leprosy	0.00044	0.0121	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IFNG—leprosy	0.000439	0.012	CbGpPWpGaD
Tolmetin—Chest pain—Thalidomide—leprosy	0.000432	0.0132	CcSEcCtD
Tolmetin—Oedema—Thalidomide—leprosy	0.000415	0.0127	CcSEcCtD
Tolmetin—Thrombocytopenia—Thalidomide—leprosy	0.000406	0.0124	CcSEcCtD
Tolmetin—PTGS1—Overview of nanoparticle effects—TNF—leprosy	0.000397	0.0109	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IFNG—leprosy	0.000391	0.0107	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—leprosy	0.000382	0.0105	CbGpPWpGaD
Tolmetin—Somnolence—Thalidomide—leprosy	0.000369	0.0113	CcSEcCtD
Tolmetin—Dyspepsia—Thalidomide—leprosy	0.000365	0.0112	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—TNF—leprosy	0.000358	0.00981	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IFNG—leprosy	0.000355	0.00973	CbGpPWpGaD
Tolmetin—Constipation—Thalidomide—leprosy	0.000355	0.0108	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL10—leprosy	0.000351	0.0096	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL2—leprosy	0.000348	0.00953	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—leprosy	0.000347	0.00951	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IFNG—leprosy	0.000345	0.00945	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Thalidomide—leprosy	0.000339	0.0104	CcSEcCtD
Tolmetin—TDO2—Metabolism—SDHD—leprosy	0.000339	0.00929	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—leprosy	0.000332	0.00908	CbGpPWpGaD
Tolmetin—Urticaria—Thalidomide—leprosy	0.000329	0.0101	CcSEcCtD
Tolmetin—Body temperature increased—Thalidomide—leprosy	0.000328	0.01	CcSEcCtD
Tolmetin—Abdominal pain—Thalidomide—leprosy	0.000328	0.01	CcSEcCtD
Tolmetin—MPO—testis—leprosy	0.000323	0.0367	CbGeAlD
Tolmetin—MPO—nervous system—leprosy	0.000317	0.036	CbGeAlD
Tolmetin—CXCL8—Allograft Rejection—IL2—leprosy	0.000316	0.00865	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—TNF—leprosy	0.000315	0.00863	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—leprosy	0.000308	0.00845	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL2—leprosy	0.000306	0.0084	CbGpPWpGaD
Tolmetin—Asthenia—Thalidomide—leprosy	0.000297	0.00909	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—leprosy	0.000284	0.00779	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.000284	0.00779	CbGpPWpGaD
Tolmetin—Diarrhoea—Thalidomide—leprosy	0.000284	0.00867	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IFNG—leprosy	0.000283	0.00775	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—IL2—leprosy	0.000279	0.00766	CbGpPWpGaD
Tolmetin—Dizziness—Thalidomide—leprosy	0.000274	0.00838	CcSEcCtD
Tolmetin—Vomiting—Thalidomide—leprosy	0.000264	0.00806	CcSEcCtD
Tolmetin—Headache—Thalidomide—leprosy	0.00026	0.00794	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—IFNG—leprosy	0.000258	0.00706	CbGpPWpGaD
Tolmetin—Nausea—Thalidomide—leprosy	0.000246	0.00753	CcSEcCtD
Tolmetin—PTGS1—skin of body—leprosy	0.000243	0.0276	CbGeAlD
Tolmetin—PTGS2—skin of body—leprosy	0.000232	0.0264	CbGeAlD
Tolmetin—CXCL8—Allograft Rejection—TNF—leprosy	0.00023	0.0063	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL2—leprosy	0.000229	0.00627	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—leprosy	0.000224	0.00615	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—leprosy	0.000199	0.00546	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—leprosy	0.000187	0.00514	CbGpPWpGaD
Tolmetin—PTGS1—tendon—leprosy	0.000185	0.021	CbGeAlD
Tolmetin—PTGS1—Selenium Micronutrient Network—IFNG—leprosy	0.00018	0.00493	CbGpPWpGaD
Tolmetin—PTGS2—tendon—leprosy	0.000177	0.0201	CbGeAlD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—leprosy	0.000167	0.00457	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—leprosy	0.000155	0.00425	CbGpPWpGaD
Tolmetin—PTGS1—testis—leprosy	0.000153	0.0174	CbGeAlD
Tolmetin—PTGS1—nervous system—leprosy	0.00015	0.0171	CbGeAlD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—leprosy	0.000146	0.00401	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—leprosy	0.000145	0.00398	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000144	0.00396	CbGpPWpGaD
Tolmetin—PTGS2—nervous system—leprosy	0.000144	0.0163	CbGeAlD
Tolmetin—PTGS2—C-MYB transcription factor network—CD4—leprosy	0.000143	0.00392	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IFNG—leprosy	0.000143	0.00391	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—leprosy	0.000133	0.00366	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—leprosy	0.000116	0.00319	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IFNG—leprosy	0.000113	0.00309	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—leprosy	0.0001	0.00275	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—leprosy	9.24e-05	0.00253	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—leprosy	7.31e-05	0.002	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SDHD—leprosy	7.29e-05	0.002	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RIPK2—leprosy	6.05e-05	0.00166	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SDHD—leprosy	5.78e-05	0.00158	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC11A1—leprosy	5.19e-05	0.00142	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—leprosy	4.97e-05	0.00136	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—leprosy	4.52e-05	0.00124	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—leprosy	4.1e-05	0.00112	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—leprosy	2.42e-05	0.000664	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD4—leprosy	1.65e-05	0.000451	CbGpPWpGaD
